View All Documents & Correspondence
A Composition Comprising Phycocyanin, And At Least One Mineral And Uses Thereof
Abstract: The present disclosure provides a composition comprising phycocyanin and zinc sulfate, which at particular w/w ratios provides enhanced bone health. Also provided are formulations and methods of improving bone health.
Notices, Deadlines & Correspondence
Patent Information
Applicants
ITC LIMITED
Inventors
1. DSOUZA, Avin
2. NARAYANAPERUMAL, Jeyaparthasarathy
3. MIRIYALA, Amarnath
4. GOPAL, Ganesh
Specification
Claims:1. A composition for enhancing alkaline phosphatase activity of osteoblast cells, said composition comprising:
a. phycocyanin; and
b. zinc sulfate,
wherein phycocyanin to zinc sulfate w/w ratio in said composition is in the range of 1:1-10:1.
2. The composition as claimed in claim 1, wherein phycocyanin to zinc sulfate w/w ratio is in the range of 2.78:1-6.94:1.
3. The composition as claimed in any of the claims 1-2, wherein phycocyanin weight concentration in said composition is in the range of 15-25µg/ml, and zinc sulfate weight concentration in said composition is in the range of 2-10µg/ml.
4. A method of preparing a composition as claimed in any of the claims 1-3.
5. A formulation for enhancing alkaline phosphatase activity of osteoblast cells, said formulation comprising:
a. phycocyanin;
b. zinc sulfate; and
c. at least one suitable carriers, diluent, and excipient,
wherein phycocyanin to zinc sulfate w/w ratio in said formulation is in the range of 1:1-10:1.
6. The formulation as claimed in claim 6, wherein phycocyanin to zinc sulfate w/w ratio in said formulation is in the range of 2.78:1-6.94:1.
7. A method of preparing a formulation as claimed in any of the claims 5-6.
8. A method of promoting bone health, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-3; and
b. contacting said composition with bone tissue,
wherein said method promotes bone health.
9. A method of promoting bone health, said method comprising:
a. obtaining a formulation as claimed in any of the claims 5-6; and
b. contacting said formulation with bone tissue,
wherein said method promotes bone health.
10. A composition as claimed in any of the claims 1-2, optionally further comprises at least one suitable carrier, diluent, and excipient for use in promoting bone health.
, Description:N/A
Documents
Orders
| Section | Controller | Decision Date |
|---|---|---|
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 5684-CHE-2015-RELEVANT DOCUMENTS [14-08-2023(online)].pdf | 2023-08-14 |
| 1 | Form 5 [21-10-2015(online)].pdf | 2015-10-21 |
| 2 | 5684-CHE-2015-IntimationOfGrant27-10-2021.pdf | 2021-10-27 |
| 2 | Form 3 [21-10-2015(online)].pdf | 2015-10-21 |
| 3 | Drawing [21-10-2015(online)].pdf | 2015-10-21 |
| 3 | 5684-CHE-2015-PatentCertificate27-10-2021.pdf | 2021-10-27 |
| 4 | Description(Complete) [21-10-2015(online)].pdf | 2015-10-21 |
| 4 | 5684-CHE-2015-US(14)-HearingNotice-(HearingDate-22-09-2021).pdf | 2021-10-17 |
| 5 | 5684-CHE-2015-Written submissions and relevant documents [06-10-2021(online)].pdf | 2021-10-06 |
| 5 | 5684-CHE-2015-Power of Attorney-261115.pdf | 2016-06-01 |
| 6 | 5684-CHE-2015-Form 1-261115.pdf | 2016-06-01 |
| 6 | 5684-CHE-2015-Correspondence to notify the Controller [17-09-2021(online)].pdf | 2021-09-17 |
| 7 | 5684-CHE-2015-DRAWING [21-04-2021(online)].pdf | 2021-04-21 |
| 7 | 5684-CHE-2015-Correspondence-F1-PA-261115.pdf | 2016-06-01 |
| 8 | 5684-CHE-2015-FORM 18 [05-09-2019(online)].pdf | 2019-09-05 |
| 8 | 5684-CHE-2015-FER_SER_REPLY [21-04-2021(online)].pdf | 2021-04-21 |
| 9 | 5684-CHE-2015-FER.pdf | 2020-07-22 |
| 9 | 5684-CHE-2015-OTHERS [21-04-2021(online)].pdf | 2021-04-21 |
| 10 | 5684-CHE-2015-FORM 4(ii) [19-01-2021(online)].pdf | 2021-01-19 |
| 11 | 5684-CHE-2015-FER.pdf | 2020-07-22 |
| 11 | 5684-CHE-2015-OTHERS [21-04-2021(online)].pdf | 2021-04-21 |
| 12 | 5684-CHE-2015-FER_SER_REPLY [21-04-2021(online)].pdf | 2021-04-21 |
| 12 | 5684-CHE-2015-FORM 18 [05-09-2019(online)].pdf | 2019-09-05 |
| 13 | 5684-CHE-2015-Correspondence-F1-PA-261115.pdf | 2016-06-01 |
| 13 | 5684-CHE-2015-DRAWING [21-04-2021(online)].pdf | 2021-04-21 |
| 14 | 5684-CHE-2015-Correspondence to notify the Controller [17-09-2021(online)].pdf | 2021-09-17 |
| 14 | 5684-CHE-2015-Form 1-261115.pdf | 2016-06-01 |
| 15 | 5684-CHE-2015-Power of Attorney-261115.pdf | 2016-06-01 |
| 15 | 5684-CHE-2015-Written submissions and relevant documents [06-10-2021(online)].pdf | 2021-10-06 |
| 16 | 5684-CHE-2015-US(14)-HearingNotice-(HearingDate-22-09-2021).pdf | 2021-10-17 |
| 16 | Description(Complete) [21-10-2015(online)].pdf | 2015-10-21 |
| 17 | 5684-CHE-2015-PatentCertificate27-10-2021.pdf | 2021-10-27 |
| 17 | Drawing [21-10-2015(online)].pdf | 2015-10-21 |
| 18 | 5684-CHE-2015-IntimationOfGrant27-10-2021.pdf | 2021-10-27 |
| 18 | Form 3 [21-10-2015(online)].pdf | 2015-10-21 |
| 19 | Form 5 [21-10-2015(online)].pdf | 2015-10-21 |
| 19 | 5684-CHE-2015-RELEVANT DOCUMENTS [14-08-2023(online)].pdf | 2023-08-14 |
Search Strategy
| 1 | 201741002395searchreport(1)E_15-07-2020.pdf |